Novo Nordisk A/S

Stock Chart, Company Information, and Scan Results

$67.22(as of Jul 15, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Novo Nordisk A/S Company Information, Fundamentals, and Technical Indicators

Stock Price$67.22
Ticker SymbolNVO
ExchangeNyse
SectorHealthcare
IndustryDrug Manufacturers - General
Employees77,406
CountyUSA
Market Cap$305,858.9M
EBIDTA155,285.0M
10-Day Moving Average69.54
P/E Ratio2.93
20-Day Moving Average70.92
Forward P/E Ratio16.67
50-Day Moving Average70.23
Earnings per Share3.69
200-Day Moving Average85.70
Profit Margin37.18%
RSI44.58
Shares Outstanding3,368.5M
ATR1.98
52-Week High140.68
Volume6,007,256
52-Week Low57.00
Most Recent Support Level68.65
Book Value138,540.0M
Most Recent Resistance Level71.75
P/B Ratio2.21
Upper Keltner75.37
P/S Ratio1.01
Lower Keltner66.47
Debt-to-Equity Ratio75.37
Next Earnings Date08/06/2025
Cash Surplus-197,179.0M
Next Ex-Dividend DateUnknown

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with UNICEF to tackle childhood obesity; and with Valo Health, Inc. to discover and develop novel drug programmes for cardiometabolic space. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Novo Nordisk A/S In Our Stock Scanner

example chart graphic
Date: Jul 15, 2025Scan Name: Low PS RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Date: Jul 15, 2025Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---
example chart graphic
Date: Jul 15, 2025Scan Name: Downtrending StocksScan Type: Stock Fundamentals
As of ---
example chart graphic
Date: Jul 15, 2025Scan Name: Low PE RatiosScan Type: Stock Fundamentals
As of ---
example chart graphic
Date: Jul 15, 2025Scan Name: Undervalued StocksScan Type: Stock Fundamentals
As of ---
example chart graphic
Date: Jul 15, 2025Scan Name: Blue Chip Stocks with Low PE RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Date: Jul 15, 2025Scan Name: Discounted Stocks with Earnings GrowthScan Type: Stock Fundamentals
As of ---
example chart graphic
Date: May 20, 2025Scan Name: Heikin Ashi BreakoutScan Type: Candlestick Pattern Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.